'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain."
Oct 13, 2025
0
61
Organic Chemicals: News and Research on Cyclodecanes
MeSH tree: D02.455.426.392.368.242
How does chemotherapy disrupt circadian rhythms?
During and after chemotherapy, nearly half of cancer patients endure circadian rhythm disruptions, which worsens treatment side effects. Because the body's primary rhythm pacemaker is in the brain, this suggests that perhaps ...
Sep 8, 2025
1
13
Drug-coated devices do not improve outcomes in patients with peripheral artery disease, study finds
Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), according to late-breaking research ...
Sep 1, 2025
0
11
Molecular test helps tailor chemotherapy for advanced prostate cancer patients
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, ...
Aug 28, 2025
0
23
Repackaged cancer drug boosts delivery to tumors, improves combination therapies
University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than standard forms of chemotherapy. ...
Aug 21, 2025
0
32
Cellular signature explains why some prostate tumors resist standard treatments
A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Jul 9, 2025
0
19
Oncolytic virus immunotherapy shows promise in HR+/HER2- breast cancer trial
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of pelareorep, an investigational oncolytic virus immunotherapy, when added to ...
Jun 24, 2025
0
29
Researchers identify potential drug combinations to improve breast cancer treatment: Q&A with professor of pharmacology
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become exhausted and stop.
Mar 28, 2025
0
31
Study finds cryotherapy treatment is effective in reducing neuropathy in breast cancer patients
A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer patients from nerve pain caused by chemotherapy.
Feb 20, 2025
0
21
Pancreatic cancer: Blocked nerves as a possible new treatment strategy
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine ...
Feb 17, 2025
0
63
